• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

The Top 5 Biosimilar Articles for the Week of November 9

Video

Here are the top 5 biosimilar articles for the week of November 9, 2020.

Hi, I’m Skylar Jeremias for The Center for Biosimilars®, your resource for clinical, regulatory, business, and policy news in the rapidly changing world of biosimilars.

Here are the top 5 biosimilar articles for the week of November 9, 2020.

Number 5: Investigators at the American College of Rheumatology (ACR) Convergence 2020 meeting presented evidence of what they say are successful, first-time tests of a multibiomarker disease activity (MBDA) score in patients with rheumatoid arthritis (RA).

Number 4: Medicines for Europe, a generic and biosimilar trade association, contends in a white paper that legal and regulatory loopholes increasingly keep competing drugs off the market

Number 3: Separate studies including one on application methods for Celltrion’s adalimumab biosimilar (CT-P17) were reported at the ACR Convergence 2020 meeting.

Number 2: Alberta, Canada’s deadline for switching patients to biosimilars is months away, but the province has already seen some success with the new program.

Number 1: Biosimilar developments reported at the ACR Convergence 2020 virtual meeting included data from safety and efficacy trials for Pfizer and Celltrion versions of adalimumab.

To read all of these articles and more, visit centerforbiosimilars.com.

Recent Videos
Here are the top 5 biosimilar articles for the week of December 9, 2024.
Steve Pickette, PharmD
Here are the top 5 biosimilar articles for the week of December 2, 2024.
Here are the top 5 biosimilar articles for the week of November 25, 2024.
Here are the top 5 biosimilar articles for the week of November 18, 2024.
global biosimilars week join the movement
The Top 5 Biosimilar Articles of the Week.
Sophia Humphreys, PharmD
The Top 5 Biosimilar Articles of the Week.
The Top 5 Biosimilar Articles of the Week.
Related Content
© 2024 MJH Life Sciences

All rights reserved.